CVX
28
3
WY
56
2
M
53
-5
MTCH
70
11
AES
54
7
MMM
52
-4
PNW
55
2
MRK
66
3
CVS
40
3
OKE
65
3
KMX
38
-9
SWK
61
6
D
35
-6
ZBH
44
2
XOM
50
5
NUE
54
-4
CHRW
79
-3
PGR
44
2
ITW
40
3
NOC
58
4
CVX
28
3
WY
56
2
M
53
-5
MTCH
70
11
AES
54
7
MMM
52
-4
PNW
55
2
MRK
66
3
CVS
40
3
OKE
65
3
KMX
38
-9
SWK
61
6
D
35
-6
ZBH
44
2
XOM
50
5
NUE
54
-4
CHRW
79
-3
PGR
44
2
ITW
40
3
NOC
58
4
Financhill
Back

The Allstate Corp. Vs. Oruka Therapeutics, Inc. Industry Stock Comparison

Buy
61

ALL
The Allstate Corp.

Last Price:
$209.81
Seasonality Move:
1.92%
Sell
40

ORKA
Oruka Therapeutics, Inc.

Last Price:
$32.34
Seasonality Move:
-10.99%
Buy
61
The Allstate Corp. (ALL) is a Buy

Is The Allstate Corp. a Buy, Sell or Hold?

  • The current The Allstate Corp. [ALL] share price is $208.28. The Score for ALL is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • ALL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Oruka Therapeutics, Inc. (ORKA) is a Sell

Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Oruka Therapeutics, Inc. [ORKA] share price is $31.97. The Score for ORKA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ORKA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ALL Stock Price Chart

What is The Allstate Corp.'s stock price today?

  • The The Allstate Corp. share price today is $208.28
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALL is experiencing buying pressure, which is a positive indicator for future bullish movement.

ORKA Stock Price Chart

What is Oruka Therapeutics, Inc.'s stock price today?

  • The Oruka Therapeutics, Inc. share price today is $31.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing slight buying pressure.

ALL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.39 Buy
Relative Strength Index (14 RSI): 53.16 Buy
Chaikin Money Flow: 1423213 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (204.43 - 212.29) Sell
Bollinger Bands (100): (198.37 - 211.05) Buy

ORKA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.74 Buy
Relative Strength Index (14 RSI): 61.53 Buy
Chaikin Money Flow: 394649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.23 - 31.09) Buy
Bollinger Bands (100): (15.89 - 28.91) Buy

ALL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 207.84 Buy
20-day SMA: 207.69 Buy
50-day SMA: 203.41 Buy
200-day SMA: 202.13 Buy
8-day EMA: 207.03 Buy
20-day EMA: 206.89 Buy
50-day EMA: 205.58 Buy
200-day EMA: 200.56 Buy

ORKA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.97 Buy
20-day SMA: 30.06 Buy
50-day SMA: 28.52 Buy
200-day SMA: 16.89 Buy
8-day EMA: 30.34 Buy
20-day EMA: 29.78 Buy
50-day EMA: 27.54 Buy
200-day EMA: 21.05 Buy

The Allstate Corp. Earnings Growth & ALL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $12.16 per share, and a decrease next year of $4.93 per share.

Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and a decrease next year of $0.32 per share.

The Allstate Corp. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oruka Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):